---
:id: aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9GTFUwMDEvVjEjUFI=
:uri: http://www.transceleratebiopharmainc.com/FLU001/V1#PR
:rdf_type: http://www.assero.co.uk/Protocol#Protocol
:label: FLU 001
:has_state:
  :id: aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9GTFUwMDEvVjEjUFJfUlM=
  :uri: http://www.transceleratebiopharmainc.com/FLU001/V1#PR_RS
  :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationState
  :registration_status: Incomplete
  :administrative_note: ''
  :effective_date: '2016-01-01T00:00:00+00:00'
  :until_date: '2016-01-01T00:00:00+00:00'
  :unresolved_issue: ''
  :administrative_status: ''
  :previous_state: Incomplete
  :multiple_edit: false
  :by_authority:
    :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvUkEjRFVOUzA3OTY1ODY4NA==
    :uri: http://www.assero.co.uk/RA#DUNS079658684
    :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationAuthority
    :organization_identifier: '079658684'
    :international_code_designator: DUNS
    :owner: true
    :ra_namespace:
      :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjVFJBTlNDRUxFUkFURQ==
      :uri: http://www.assero.co.uk/NS#TRANSCELERATE
      :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
      :short_name: Transcelerate
      :name: TransCelerate BioPharma Inc.
      :authority: www.transceleratebiopharmainc.com
:has_identifier:
  :id: aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9GTFUwMDEvVjEjUFJfU0k=
  :uri: http://www.transceleratebiopharmainc.com/FLU001/V1#PR_SI
  :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
  :identifier: FLU001
  :version_label: ''
  :version: 1
  :semantic_version: 0.1.0
  :has_scope:
    :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjVFJBTlNDRUxFUkFURQ==
    :uri: http://www.assero.co.uk/NS#TRANSCELERATE
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
    :short_name: Transcelerate
    :name: TransCelerate BioPharma Inc.
    :authority: www.transceleratebiopharmainc.com
:has_previous_version: 
:origin: ''
:change_description: ''
:creation_date: '2016-01-01T00:00:00+00:00'
:last_change_date: '2020-11-16T15:05:45+01:00'
:explanatory_comment: ''
:acronym: MADE UP ACRONYM
:title: A made up protocol title
:short_title: FLU 001
:study_phase: 
:study_type: 
:intervention_model: 
:masking: 
:for_indication: []
:in_ta: 
:specifies_arm:
- :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQVJNIzE3NjBjYmIxLWEzNzAtNDFmNi1hM2IzLTQ5M2MxZDljMjIzOA==
  :uri: http://www.assero.co.uk/ARM#1760cbb1-a370-41f6-a3b3-493c1d9c2238
  :rdf_type: http://www.assero.co.uk/Protocol#Arm
  :label: B
  :description: ''
  :arm_type: ''
  :ordinal: 2
- :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQVJNI2I3NjU5N2Y3LTk3MmYtNDBmNC1iZWQ3LWUxMzQ3MjVjZjI5Ng==
  :uri: http://www.assero.co.uk/ARM#b76597f7-972f-40f4-bed7-e134725cf296
  :rdf_type: http://www.assero.co.uk/Protocol#Arm
  :label: A
  :description: ''
  :arm_type: ''
  :ordinal: 1
:specifies_epoch:
- :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvRVAjNDY0NmI0N2EtNGFlNC00ZjIxLWI1ZTItNTY1ODE1YzhjZGVk
  :uri: http://www.assero.co.uk/EP#4646b47a-4ae4-4f21-b5e2-565815c8cded
  :rdf_type: http://www.assero.co.uk/Protocol#Epoch
  :label: Follow Up
  :ordinal: 3
- :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvRVAjMGNkYTZmMjQtZTU0ZC00NzI0LWFmNzktOTE2ZDQxZDliZDdm
  :uri: http://www.assero.co.uk/EP#0cda6f24-e54d-4724-af79-916d41d9bd7f
  :rdf_type: http://www.assero.co.uk/Protocol#Epoch
  :label: Screening
  :ordinal: 1
- :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvRVAjZjlmZTcxMjgtNGI2My00ODJkLTlhMTEtNjIyNTBlMjRmZTBj
  :uri: http://www.assero.co.uk/EP#f9fe7128-4b63-482d-9a11-62250e24fe0c
  :rdf_type: http://www.assero.co.uk/Protocol#Epoch
  :label: Treatment
  :ordinal: 2
:specifies_objective: []
